We caught up with a group of top executives at Recordati at ENDO 2025 and asked them about their plans, challenges and opportunities and, importantly, their outlook for new therapies in acromegaly and Cushing’s.
Industry News
News from pharmaceutical companies and other related healthcare organizations
Perspectives from inside Endo 2025 – My chats with Crinetics Pharmaceuticals’ Jacqui Kirby, Stephanie Kallay, and Dr. Peter Trainer
September 3, 2025
Through our conversations with leading pituitary experts, physicians, nurses, industry executives, researchers, patient advocates, and other key stakeholders, we gain unique insights from the fascinating world of pituitary disease research and treatment.
New clinical trial aims to understand hypertension’s connection to hypercortisolism
March 13, 2025
Corcept Therapeutics recently announced the initiation of a clinical trial – called Momentum – to examining the prevalence of endogenous hypercortisolism (Cushing’s syndrome) in patients with resistant hypertension. The trial will enroll 1,000 patients across 45
Acromegaly: a discussion about psychological and emotional health support initiatives
February 27, 2025
Today's podcast is about an important Chiesi Rare Diseases initiative to learn more about the psychological, social, and emotional health issues facing acromegaly patients. We talked to Stuart Siedman, Chiesi's Vice President of advocacy. Stuart
TV commercial highlights cortisol issues in type 2 diabetes
January 17, 2025
A new TV ad links cortisol imbalance to Type 2 diabetes—raising awareness of overlooked endocrine factors.
Podcast series with industry leaders: meet Dr. Scott Pescatore, Head of Global Operations at Recordati Rare Diseases.
November 14, 2024
I am pleased to welcome Dr. Scott Pescatore to the Pituitary Podcast. In today's podcast, we discuss some of the work being done in the pituitary and adrenal space. Dr. Pescatore's - and other industry
Hello AI. What’s new in the world of pituitary disease?
August 1, 2024
We often scan the pituitary universe and report on the latest drug developments, new potential therapies, and engaging clinical cases and resources. We hope this knowledge helps people gain more insight into these complicated diseases and the fascinating medical/scientific discovery, research, and diagnosis world.
A conversation with Recordati’s Dr. Mario Maldonado
July 11, 2024
Today's podcast features my chat with Dr. Mario Maldonado, Head of Development and Global Endocrinology at Recordati Rare Diseases. Dr. Maldonado brings a wealth of experience and a great perspective on drug development. He was
Drug shortages and insurance issues: an ongoing challenge with no end in site
May 6, 2024
From Jorge D. Faccinetti, co-founder and chief editor: Why can’t we address some of the most critical issues affecting healthcare today? These are not just other people’s problems. They affect us, our doctors, and our
A new book. Stay tuned!
April 1, 2024
From the desk of Jorge D. Faccinetti – chief editor and co-founder – I am thrilled to announce that Pituitary World News co-founder Dr. Lewis Blevins has been working on a new book on Cushing’s
A view from across the pond: The Spanish Endocrine Society Conference
January 30, 2024
Spain and Spanish-speaking countries have been our focus as we seek to develop more content in Spanish for our edition of Pituitary Word News in Español. Today’s podcasts covers part of the conference and shares my conversations with three world-renowned Spanish endocrinologists.
Our chat with Giacomo Chiesi
January 11, 2024
In today’s podcast, we talk with Giacomo Chiesi, Head of Global Rare Diseases at the Chiesi Group, where he leads a team in developing and marketing treatments for rare and ultra-rare diseases.
Somavert turns twenty: the pegvisomant story
December 27, 2023
From J D Faccinetti, Co-founder and Chief Editor – When you deal with a chronic pituitary disease, you get close to your medications, just like you would to a friend. This was my experience with